SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-010899
Filing Date
2023-02-06
Accepted
2023-02-06 08:00:39
Documents
13
Period of Report
2023-02-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm235237d1_8k.htm   iXBRL 8-K 58952
  Complete submission text file 0001104659-23-010899.txt   300692

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pmgm-20230206.xsd EX-101.SCH 4070
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmgm-20230206_def.xml EX-101.DEF 27972
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmgm-20230206_lab.xml EX-101.LAB 39560
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmgm-20230206_pre.xml EX-101.PRE 26590
7 EXTRACTED XBRL INSTANCE DOCUMENT tm235237d1_8k_htm.xml XML 7157
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 23588423
SIC: 2834 Pharmaceutical Preparations